Pharmacokinetics of Vincristine Monotherapy in Childhood Acute Lymphoblastic Leukemia
- 1 July 2002
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Pediatric Research
- Vol. 52 (1), 113-118
- https://doi.org/10.1203/00006450-200207000-00021
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Vincristine revisitedCritical Reviews in Oncology/Hematology, 1999
- Involvement of Microtubules in the Regulation of Bcl2 Phosphorylation and Apoptosis through Cyclic AMP-Dependent Protein KinaseMolecular and Cellular Biology, 1998
- Vincristine Saturation of Cellular Binding Sites and Its Cytotoxic Activity in Human Lymphoblastic Leukemia Cells: mechanism of inoculum effectBiochemical Pharmacology, 1998
- Bcl-2 interrupts the ceramide-mediated pathway of cell death.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Characteristics of cancer cell death after exposure to cytotoxic drugs in vitroBritish Journal of Cancer, 1996
- Clinical and Cell Biological Features Related to Cellular Drug Resistance of Childhood Acute Lymphoblastic Leukemia CellsLeukemia & Lymphoma, 1995
- Apoptosis Induced by Microtubule Disrupting Drugs in Cultured Human Lymphoma Cells: Inhibitory Effects of Phorbol Ester and Zinc SulphatePathology - Research and Practice, 1993
- Kinetic analysis of tubulin exchange at microtubule ends at low vinblastine concentrationsBiochemistry, 1990
- Differences between vinblastine and vincristine in distribution in the blood of rats and binding by platelets and malignant cellsEuropean Journal of Cancer (1965), 1978
- [3H]-Vincristine. Preparation and preliminary pharmacologyJournal of Medicinal Chemistry, 1972